Equities

Qatari German Company for Medical Devices QPSC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
QGMD:DSM

Qatari German Company for Medical Devices QPSC

Actions
Health CareMedical Equipment and Services
  • Price (QAR)1.43
  • Today's Change-0.017 / -1.17%
  • Shares traded6.20m
  • 1 Year change-23.84%
  • Beta0.9015
Data delayed at least 15 minutes, as of Jul 13 2025 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Qatari German Company for Medical Devices QPSC is a Qatar-based manufacturer of medical devices. The Company is engaged in the manufacture of single use disposable syringes and trading in medical equipment, tools and supplies. Its product portfolio includes Q JectUltra, an insulin syringe used in diabetic care; Q Flow, specially designed for infusion therapy; Q Need, a single-use hypodermic needle; Q Ject, a single-use syringe specifically intended for administering curative medications; Q Safe, a syringe designed to prevent reuse, enhancing patient safety, among others.

  • Revenue in QAR (TTM)5.18m
  • Net income in QAR-70.37m
  • Incorporated2000
  • Employees6.00
  • Location
    Qatari German Company for Medical Devices QPSCQG Medical Devices, 22556PO BoxDOHA QatarQAT
  • Phone+974 44581201
  • Fax+974 44581328
  • Websitehttps://www.qgmd.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Allmed Solutions Ltd0.00-9.57m35.10m22.00--0.8166-----0.0928-0.09280.000.4090.00----0.00-16.84-9.16-18.72-10.12--55.39---170.44----0.0145-------715.47--8.08--
Nissan Medical Industries Ltd688.28m-3.37m108.96m406.00--0.42813.940.1583-0.3688-0.368881.4125.620.88994.156.751,550,310.00-0.67123.80-1.387.1111.9518.52-0.75423.900.45750.54270.3748---9.521.8739.95-12.83-9.20--
Pulsenmore Ltd10.56m-40.17m148.98m63.00--1.40--14.10-0.717-0.7170.18861.930.06010.26017.41153,349.20-22.84-23.53-25.07-25.3237.03---380.25-555.167.66--0.2063--56.12--37.28--23.66--
Qatari German Co for Medical Device QPSC5.18m-70.37m167.24m6.00------32.30-0.6092-0.60920.0448-0.29480.03030.24820.1991---41.14-7.00-497.40-12.82-0.184629.16-1,359.03-43.840.0237-5.421.29---64.154.12-5,226.27---15.71--
Epitomee Medical Ltd0.00-5.33m297.30m42.00--2.37-----0.1642-0.16420.003.820.00----0.00-3.64-18.00-3.85-18.81-------372.228.99--0.1135---100.00--74.23--107.15--
Ilex Medical Ltd1.00bn44.72m765.37m176.0017.111.087.780.76193.663.0582.0857.780.92494.423.635,219,784.004.1212.095.7117.2423.3329.664.4511.172.02--0.070932.690.45017.74-17.69-5.381.29--
Data as of Jul 13 2025. Currency figures normalised to Qatari German Company for Medical Devices QPSC's reporting currency: QAR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.